Proqr Therapeutics Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$1.71

+0.09 (+5.56%)

As of Apr 1, 10:07 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +438.0% upside

Low Target $6.27

Average Target $9.20

High Target $10.38

Current Price $1.71

Current
$1.71

Target
$9.20

$6.27 $9.20 avg $10.38

Scenario Analysis

Bear Case

$6.27

266.7%

Low target

Base Case

$9.20

+438.0%

Avg target

Bull Case

$10.38

+507.0%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.10

-44.8% from high

52-Week Low

$1.07

+59.8% from low

Target vs 52W High

$9.20

+196.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%